ICON provides its full range of clinical, consulting and commercial services across several sectors.
ICON can support product design, development and registration, regulatory support and commercialisation of Biosimilars.
ICON provides full service outsourcing and flexible support for biotech specific needs such as due diligence and asset valuation.
ICON provides federal and NGO clients with development and staffing services across areas such as vaccines, biothreats response and working in Africa.
ICON understands the unique requirements of medical devices, diagnostics, and combination drug/device and biologic/device products.
ICON has worked with many of the world’s pharmaceutical firms, developing strategic partnerships with some of the world’s largest.